In August 2024, RMMS secured a favorable jury verdict on behalf of its client, Fresenius Kabi USA, LLC, in defense of patent infringement claims asserted by HQ Specialty Pharma Corp. and WG Critical Care, LLC. The litigation involved Fresenius Kabi’s Calcium Gluconate in Sodium Chloride Injection products in freeflex® bags.
More specifically, on August 30, 2024, a Delaware jury found that asserted claims of U.S. Patent No. 10,130,646 were invalid for improper inventorship following a five-day jury trial. As a result, the ‘646 patent was found invalid and plaintiffs HQ and WG Critical Care were awarded no damages.
This victory affirms RMMS’ reputation as a leading trial option in connection with litigation regarding pharmaceutical patents.
RMMS attorneys appearing for Fresenius Kabi included William A. Rakoczy, Paul J. Molino, Heinz J. Salmen, Eric R. Hunt, Matthew V. Anderson, Kevin P. Burke, Conly S. Wythers, Ty W. Callahan, and Adrianne C. Rose.